LES ÉPIDEMIES DE FIÈVRE HÉMORAGIQUE DUES AU VIRUS EBOLA EN AFRIQUE CENTRALE (2001-2003).
OUTBREAKS OF EBOLA HAEMORRHAGIC FEVERS IN CENTRAL AFRICA (2001-2003).
Bibliographie
bibliography
• quelques liens utiles de documentation sur Ebola
• sélection de quelques articles se rapportant aux 4 séances d'atelier
Session 1.
Réponses aux épidémies : épidémiologie de terrain, contrôle et prévention, surveillance
Outbreak Responses: field epidemiology, control and prevention, surveillance
Session 2.
La prise en charge des cas d'Ebola et les mesures de contrôle de l'infection
Clinical management and Infection control for VHF patients
Session 3.
Mobilisation sociale et anthropologie médicale
Social mobilization and medical anthropology
Session 4.
Écologie et histoire naturelle des Filovirus
Ecology and natural history of Filoviruses
Revue critique des recommandations des quatre sessions et conclusion de la réunion
Critical review of the recommendations and conclusion of the workshop
Sélection de quelques articles se rapportant au virus MARBURG
quelques liens utiles pour de la documentation sur Ebola :
[retour haut de page]
sélection de quelques articles se rapportant aux 4 séances d'atelier :
Session 1.
Réponses aux épidémies : épidémiologie de terrain, contrôle et prévention, surveillance
Outbreak Responses: field epidemiology, control and prevention, surveillance
Épidémie GABON CONGO
- ARTHUR RR Ebola en Afrique : Découvertes au cours des dix dernières années. Eurosurveillance, 2002, 7, 33-36.
- BOUMANDOUKI P, FORMENTY P, EPELBOIN A, CAMPBELL P, ATSANGANDOKO C, ALLARANGAR Y, LEROY EM, KONE ML, MOLAMOU A, DINGA-LONGA O, SALEMO A, KOUNKOU R Y, MOMBOULI V, IBARA J R, GATURUKU P, NKUNKU S. Prise en charge des malades et des défunts lors de l’épidémie de fièvre hémorragique à virus Ebola à Mbandza et Mbomo d’octobre à décembre 2003 au Congo. Bull Soc Pathol Exot. 2005, 98, 218-223.
[télécharger l'article / download article] (544 Ko)
- DAS P Infectious disease surveillance update. The Lancet Infectious Diseases, 2002, 2, 69.
- FORMENTY P, EPELBOIN A, ALLARANGAR Y, LIBAMA F, BOUMANDOKI P, KONE L, MOLAMOU A, GAMI N, MOMBOULI J-V, GUARDOMARTINEZ M & NGAMPO S Séminaire de formation des formateurs et analyse des épidémies de fièvres hémorragiques à virus Ebola en Afrique centrale de 2001 à 2003. Bull Soc Pathol Exot. 2005, 98, 244-254.
[télécharger l'article / download article] (360 Ko)
- FORMENTY P, LIBAMA F, EPELBOIN A, ALLARANGAR Y, LEROY E et al. L’épidémie de fièvre hémorragique a virus Ebola en République du Congo, 2003 : une nouvelle stratégie ? Méd Trop, 2003, 63, 291295.
- GEORGES AJ, LEROY EM, RENAUT AA, TEVI BENISSAN C, NABIAS RJ et al. Ebola Hemorrhagic Fever Outbreaks in Gabon, 19941997: Epidemiologic and Health Control Issues. J Infect Dis, 1999, 179, S 6575.
- H RATEL La nouvelle plaie de l’Afrique. Sciences et Avenir, 2003, 79.
- KERR C Jungle conceals Ebola origins. The Lancet Infectious Diseases, 2002, 2, 69.
- LEROY EM, SOUQUIERE S, ROUQUET P & DREVET D Reemergence of ebola haemorrhagic fever in Gabon. The Lancet, 2002, 359, 712.
- Organisation Mondiale de la Santé Flambée(s) de fièvre hémorragique à virus Ebola, Congo et Gabon, octobre 2001juillet 2002. Relevé Épidémiologique Hebdomadaire, 2003, 26, 223228.
- Organisation Mondiale de la Santé Flambée(s) de fièvre hémorragique à virus Ebola, République du Congo, janvieravril 2003. Relevé Épidémiologique Hebdomadaire, 2003, 78, 285296.
- Organisation Mondiale de la Santé Syndrome respiratoire aigu sévère (SRAS) : 100e jour de la flambée. Relevé Epidémiologique Hebdomadaire, 2003, 78, 217228.
- TALANI P, KONONGO JD, GROMYKO AI, NANGAMANIANE J, YALA F & BODZONGO D Prévalence des anticorps antifièvres hémorragiques d’origine virale dans la région du Pool (CongoBrazzaville). Méd Afr Noire, 1999, 46, 424427.
- NKOGHE D, FORMENTY P, LEROY EM, NNEGUE S, OBAME EDOU SY, IBA BA J, ALLARANGAR Y, CABORE J, Bachy C, ANDRAGHETTI R, de BENOIST AC, GALANIS E, ROSE A, BAUSCH D, REYNOLDS M, ROLLIN P, CHOUEIBOU C, SHONGO R, GERGONNE B, KONÉ ML, YADA A, ROTH C & TOUNG MVE M Plusieurs épidémies de fièvre hémorragique à virus Ebola au Gabon, octobre 2001 à avril 2002. Bull Soc Pathol Exot. 2005, 98, 224-229.
[télécharger l'article / download article] (328 Ko)
Épidémie OUGANDA
- Anonymous From the Centers for Disease Control and Prevention. Outbreak of Ebola hemorrhagic fever, Uganda, August 2000-January 2001. JAMA, 2001, 285,1010-1012.
- Anonymous Outbreak of Ebola hemorrhagic fever, Uganda, August 2000-January 2001. Can Commun Dis Rep, 2001, 27, 49-53.
- BITEKYEREZO M, KYOBUTUNGI C, KIZZA R, MUGENI J, MUNYARUGERO E, et al. - The outbreak and control of Ebola viral haemorrhagic fever in a Ugandan medical school. Trop Doct, 2002, 32, 10-15.
- HYDE-PRICE C - Under siege. An outbreak of the Ebola virus in Uganda has already taken its toll on nurses. Nurs Stand, 2000, 15, 20.
- JEPPSSON A Alarmingly protracted ebola epidemics in Uganda. Lakartidningen, 2001, 98, 1810. Swedish.
- LOVGREN S A killer virus pays a visit. Can Uganda contain the Ebola outbreak? US News World Rep. 2000, 129, 39.
- MACDONALD R Ebola virus claims more lives in Uganda. BMJ, 2000, 321, 1037.
- MAURICE J - The Uganda Ebola outbreak not all negative. Bull World Health Organ, 2000, 0, 1476-1477.
- Morbidity and Mortality Weekly Report Outbreak of Ebola Hemorrhagic Fever - Uganda, August 2000January 2001. 2001, 50, 73-77.
- Organisation Mondiale de la Santé Flambée de fièvre hémorragique à virus Ebola, Ouganda, août 2000janvier 2001. Relevé Epidémiologique Hebdomadaire, 2001, 76, 41-48.
- RODHAIN F, GONZALEZ JP, MERCIER E, HELYNCK B, LAROUZE B & HANNOUN C - Arbovirus infections and viral haemorrhagic fevers in Uganda: a serological survey in Karamoja district, 1984. Trans R Soc Trop Med Hyg, 1989, 83, 851-854.
- WEIR E Ebola erupts again. CMAJ, 2001, 164, 685.
- WENDO C Caring for the survivors of Uganda's Ebola epidemic one year on. Lancet, 2001, 358, 1350.
LABORATOIRE
- DROSTEN C, KÜMMERER BM, SCHMITZ H & GÜNTHER S Molecular diagnostics of viral hemorrhagic fevers. Antiviral Research, 2003, 1783, 1-27.
- GROLLA A, LUCHT A, DICK D, STRONG J, FELDMANN H. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull Soc Pathol Exot, 98, 205-209.
[télécharger l'article / download article] (252 Ko)
- KSIAZEK TG, ROLLIN PE, WILLIAMS AJ et al. Clinical virology of Ebola Hemorrhagic Fever (EHF) : Virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis, 1999, 179 (suppl 1), 177-187.
- LEROY EM, BAIZE S, LU CY, et al. Diagnosis of Ebola haemorrhagic fever by RT-PCR in an epidemic setting. J Med Virol, 2000, 60, 46367.
- LUCHT A, GRUNOW R, MÖLLER P, FELDMANN H & BECKER S Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus. Journal of Virological Methods, 2003, 111, 21-28.
- LUCHT A, GRUNOW R, OTTERBEIN C, MOLLER P, FELDMANN H, BECKER S. Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus. Med Microbiol Immunol (Berl), 2004, 193 (4), 181-187. Epub 2003 Oct 31.
- MARUYAMA T, RODRIGUEZ LT, JAHRLING PB, SANCHEZ A, KHAN AS et al. Ebola Virus Can Be Effectively Neutralized by Antibody Produced in Natural Human Infection. Journal of Virology, 1999, 73, 60246030.
- MEISSNER F, MARUYAMA T, FRENTSCH M, HESSELL AJ, RODRIGUEZ LL et al. Detection of Antibodies against the Four Subtypes of Ebola Virus in Sera from Any Species Using a Novel Antibody-Phage Indicator Assay. Virology, 2002, 300, 236-243.
- NIIKURA M, IKEGAMI T, SAIJO M, KURANE I, MIRANDA ME et al. Detection of Ebola Viral Antigen by Enzyme-Linked Immunosorbent Assay Using a Novel Monoclonal Antibody to Nucleoprotein. Journal of Clinical Microbiology, 2001, 39, 3267-3271.
- PARREN PWHI, GEISBERT TW, MARUYAMA T, JAHRLING PB & BURTON DR Pre-and Postexposure Prophylaxis of Ebola Virus Infection in an Animal Model by Passive Transfer of a Neutralizing Human Antibody. Journal of Virology, 2002, 76, 6408-6412.
- TOWNER JS, ROLLIN PE, BAUSCH DG, SANCHEZ A, CRARY SM et al. Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome. Journal of Virology, 2004, 78, 4330-4341.
[retour haut de page]
Session 2.
La prise en charge des cas d'Ebola et les mesures de contrôle de l'infection
Clinical management and Infection control for VHF patients
CLINIC
- BAIZE S, LEROY EM, GEORGES AJ, GEORGES-COURBOT MC, CAPRON M, BEDJABAGA I, LANSOUD-SOUKATE J, MAVOUNGOU E. Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol, 2002, 128 (1), 163-168.
- BOSSI P, TEGNELL A, BAKA A, VAN LOOCK F, HENDRIKS J, WERNER A, MAIDHOF H, GOUVRAS G. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill, 2004, Dec, 9 (12)
- BWAKA MA, BONNET M-J, CALAIN P, COLEBUNDERS R, DE ROO A et al. - Ebola Hemorrhagic Fever in Kikwit, Democratic Republic of the Congo: Clinical Observations in 103 Patients. J Infect Dis, 1999, 179, S 1-7.
- FORMENTY P, HATZ C, LE GUENNO B, STOLL A, ROGENMOSER P & WIDMER A - Human Infection Due to Ebola Virus, Subtype Côte d’Ivoire: Clinical and Biologic Presentation. J Infect Dis, 1999, 179, S 48-53.
- GUPTA M, GREER P, MAHANTY S, SHIEH WJ, ZAKI SR, AHMED R, ROLLIN PE. CD8-mediated protection against Ebola virus infection is perforin dependent. J Immunol, 2005, 174 (7), 4198-4202.
- KALONGI Y, MWANZA K, TSHISUAKA M, LUSIAMA N, NTEMO E et al. - Isolated Case of Ebola Hemorrhagic Fever with Mucormycosis Complications, Kinshasa, Democratic Republic of the Congo. J Infect Dis, 1999, 179, S 15-17.
- KIBADI K, MUPAPA K, KUVULA K, MASSAMBA M, NDABEREY D et al. - Late Ophthalmologic Manifestations in Survivors of the 1995 Ebola Virus Epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis, 1999, 179, S 13-14.
- MUPAPA K, MUKUNDU W, BWAKA MA, KIPASA M, DE ROO A et al. - Ebola Hemorrhagic Fever and Pregnancy. J Infect Dis, 1999, 179, S 8-10.
- NDAMBI R, AKAMITUNA P, BONNET M-J, TUKADILA AM, MUYEMBE-TAMFUM J-J & COLEBUNDERS R - Epidemiologic and Clinical Aspects of the Ebola Virus Epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis, 1999, 179, S 48-53.
- ROWE AK, BERTOLLI J, KHAN AS, MUKUNU R, MUYEMBE-TAMFUM J-J et al. - Clinical, Virologic, and Immunologic Follow-Up of Convalescent Ebola Hemorrhagic Fever Patients and Their Household Contacts, Kikwit, Democratic Republic of the Congo. J Infect Dis, 1999, 179, S 28-35.
- SADEK RF, KHAN AS, STEVENS G, PETERS CJ & KSIAZEK TG - Ebola Hemorrhagic Fever, Democratic Republic of the Congo, 1995: Determinants of Survival. J Infect Dis, 1999, 179, S 24-27.
- SANCHEZ A, LUKWIYA M, BAUSCH D, MAHANTY S, SANCHEZ AJ, WAGONER KD, ROLLIN PE. Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels. J Virol, 2004, 78 (19), 10370-10377.
- SULLIVAN NJ, PETERSON M, YANG ZY, KONG WP, DUCKERS H, NABEL E, NABEL GJ. Ebola virus glycoprotein toxicity is mediated by a dynamin-dependent protein-trafficking pathway. J Virol, 2005, 79 (1), 547-553.
- WAHL-JENSEN VM, AFANASIEVA TA, SEEBACH J, STROHER U, FELDMANN H, SCHNITTLER HJ. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol, 2005, 79 (16), 10442-10450.
- ZAKI SR, SHIEH W-J, GREER PW, GOLDSMITH CS, FEREBEE T et al. - A Novel Immunohistochemical Assay for the Detection of Ebola Virus in Skin: Implications for Diagnosis, Spread, and Surveillance of Ebola Hemorrhagic Fever. J Infect Dis, 1999, 179, S 36-47.
TREATMENT AND VACCINATION
- BORIO L, INGLESBY T, PETERS CJ, SCHMALJOHN AL, HUGHES JM et al. - Hemorrhagic Fever Viruses as Biological Weapons. JAMA, 2002, 287, 2391-2405.
- BRAY M, DAVIS K, GEISBERT T, SCHMALJOHN C & HUGGINS J - A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever. J Infect Dis, 1999, 179, S 248-258.
- BRAY M, GEISBERT TW Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol, 2005, 37 (8), 1560-1566. Epub 2005 Mar 7.
- BURTON DR & PARREN PWHI - Fighting the Ebola virus. Nature, 2000, 408, 527-528.
- FELDMANN H, JONES SM, SCHNITTLER HJ, GEISBERT T. Therapy and prophylaxis of Ebola virus infections. Curr Opin Investig Drugs, 2005, 6 (8), 823-830.
- GEISBERT TW, HENSLEY LE. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med, 2004, 6 (20), 1-24.
- GEISBERT TW, HENSLEY LE, JAHRLING PB, LARSEN T, GEISBERT JB et al. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. The Lancet, 2003, 362, 1953-1958.
- GEISBERT TW, JAHRLING PB. Exotic emerging viral diseases: progress and challenges. Nat Med, 2004, 10 (12 Suppl), S110-21. Review.
- GEISBERT TW, PUSHKO P, ANDERSON K, SMITH J, DAVIS KJ et al. Evaluation in Nonhuman Primates of Vaccines against Ebola Virus. Centers for Disease Control and Prevention, 2002, 8.
- GEISBERT TW, YOUNG HA, JAHRLING PB, DAVIS KJ, KAGAN E et al. Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event. JID, 2003, 188, 1618-1629.
- HUGGINS J, ZHANG Z-X & BRAY M - Antiviral Drug Therapy of Filovirus Infections: S-Adenosylhomocysteine Hydrolase Inhibitors Inhibit Ebola Virus In Vitro and in a Lethal Mouse Model. J Infect Dis, 1999, 179, S 240-247.
- JAHRLING PB, GEISBERT TW, GEISBERT JB, SWEARENGEN JR, BRAY M et al. - Evaluation of Immune Globulin and Recombinant Interferon-a2b for Treatment of Experimental Ebola Virus Infections. J Infect Dis, 1999, 179, 224-234.
- JONES SM, FELDMANN H, STROHER U, GEISBERT JB, FERNANDO L, GROLLA A, KLENK HD, SULLIVAN NJ, VOLCHKOV VE, FRITZ EA, DADDARIO KM, HENSLEY LE, JAHRLING PB, GEISBERT TW. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med, 2005, 11 (7), 786-790. Epub 2005 Jun 5.
- KLENK HD Will we have and why do we need an Ebola vaccine? Nat Med, 2000, 6, 1322-1323.
- KUDOYAROVA-ZUBAVICHENE NM, SERGEYEV NN, CHEPURNOV AA & NETESOV SV - Preparation and Use of Hyperimmune Serum for Prophylaxis and Therapy of Ebola Virus Infections. J Infect Dis, 1999, 179, S 218-223.
- LEROY EM, BAIZE S, DEBRE P, LANSOUDSOUKATE J & MAVOUNGOU E Early immune responses accompanying human asymptomatic Ebola infections. Clin Exp Immunol, 2001 124, 453460.
- MARUYAMA T, PARREN PWHI, SANCHEZ A, RENSINK I, RODRIGUEZ LL et al. - Recombinant Human Monoclonal Antibodies to Ebola Virus. J Infect Dis, 1999, 179, S 235-239.
- MUPAPA K, MASSAMBA M, KIBADI K, KUVULA K, BWAKA A et al. - Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients. J Infect Dis, 1999, 179, S 18-23.
- NIERENGARTEN MB & LUTWICK LI Vaccines for Viral Hemorrhagic Fevers: Filoviruses and Arenaviruses. Medscape Infectious Diseases, 2002, 4.
- SULLIVAN NJ, GEISBERT TW, GEISBERT JB, XU L, YANG ZY et al. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature, 2003, 424, 681-684.
- SWENSON DL, WARFIELD KL, NEGLEY DL, SCHMALJOHN A, AMAN MJ, BAVARI S. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine, 2005, 23 (23), 3033-3042.
- WARFIELD KL, SWENSON DL, DEMMIN G, BAVARI S Filovirus-like particles as vaccines and discovery tools. Expert Rev Vaccines, 2005, 4 (3), 429-440.
VIROLOGIE
- FELDMANN H, VOLCHKOV VE, VOLCHKOVA VA, STRÖHER U & KLENK H-D Biosynthesis and role of filoviral glycoproteins. Journal of General Virology, 2001 DOI: 10.1099/vir.0.17772-0.
- LEROY EM, BAIZE S, MAVOUNGOU E & APETREI C Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving andasymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization. Journal of General Virology, 2002, 83, 67-73.
[retour haut de page]
Session 3.
Mobilisation sociale et anthropologie médicale
Social mobilization and medical anthropology
MOBILISATION SOCIALE ET ANTHROPOLOGIE
- DE ROO A, ADO B, ROSE B, GUIMARD Y, FONCK K & COLEBUNDERS R Survey among survivors of the 1995 Ebola epidemic in Kiwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health, 1998, 3, 883885.
- ECOFAC Les actions proposées dans et en périphérie du parc national d’Odzala pour le suivi des zoonoses. Canopée, 2003, 24, 1114.
- EPELBOIN A, FORMENTY P & BAHUCHET S Du virus au sorcier. Approche anthropologique de l’épidémie de fièvre hémorragique à virus Ebola (district de Kellé, Cuvette ouest, Congo, février 2003). Canopée, 2003, 24, 56.
- EPELBOIN A, FORMENTY P, BAHUCHET S & GAMI N Approche anthropologique de l'épidémie de fièvre hémorragique à virus Ebola sévissant dans le district de Kéllé (Cuvette ouest Congo). Rapport intermédiaire, 2003, 5 pp.
- GAMI N Perceptions et croyances sur Ebola dans les districts forestiers du nordCongo. Le gorille « Guil » et les différents usages coutumiers chez les Kwélé Mabéza de Sembé et Souanké. Canopée, 2003, 24, 78.
- GILMORE N & SOMERVILLE MA Stigmatisation, scapegoating and discrimination in sexually transmitted diseases: overcoming ‘them’ and ‘us’. Soc Sci Med, 1994, 39, 13391358.
- GOLDIN CS Stigmatisation and AIDS: critical issues in public health. Soc Sci Med, 1994, 39, 13591366.
- GOUDSBLOM J Pubic Health and the Civilizing Process. The Milbank Quarterly, 64, 161188.
- HEWLETT BS & AMOLA RP Cultural Contexts of Ebola in Northern Uganda. Emerg Infect Dis, 2003, 9, 12421248
- JOFFE H & HAARHOFF G Representations of farflung illnesses: the case of Ebola in Britain. Social Science & Medicine, 2002, 54, 955969.
- LOCSIN RC Ebola at Mbarara, Uganda: aesthetic expressions of the lived worlds of people waiting to know. Nurs Sci Q. 2002, 15, 123-130.
- LOCSIN RC & MATUA AG Issues and innovations in nursing practice. The lived experience of waitingtoknow: Ebola at Mbarara, Uganda, hoping for life, anticipating death. Journal of Advanced Nursing, 2002, 37, 173181
- MUYEMBE T & KIPASA M Ebola haemorrhagic fever in Kiwit, Democratic Republic of Congo. Lancet, 1995, 345, 1448.
- SANDBLADH H Role of the Red Cross movement in Uganda's Ebola outbreak. Bull World Health Organ, 2001,79, 267.
- VIVES M Le virus et le journaliste. Canopée, 2003, 24, 910.
- WELDON RA An ‘‘Urban Legend’’ of Global Proportion: An Analysis of Nonfiction Accounts of the Ebola Virus. Journal of Health Communication, 2001, 6, 281294.
[retour haut de page]
Session 4.
Écologie et histoire naturelle des Filovirus
Ecology and natural history of Filoviruses
ÉCOLOGIE
- ALLELA L, BOURY O, POUILLOT R, DELICAT A, YABA P, KUMULUNGUI B, ROUQUET P, GONZALEZ JP, LEROY EM Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis, 2005, 11 (3), 385-390.
- BERMEJO M Recensements de la faune sur le sanctuaire de gorilles de Lossi, zone affectée par le virus Ebola. Union Europenne Groupement AGRECO G.E.I.E. SECA CIRAD Forêt, 2003.
- BREMAN JG, JOHNSON KM, VAN DER GROEN G, ROBBINS CB, SZCZENIOWSKI MV et al. - A Search for Ebola Virus in Animals in the Democratic Republic of the Congo and Cameroon: Ecologic, Virologic, and Serologic Surveys, 1979-1980. J Infect Dis, 1999, 179, S 139-147.
- DASZAK P, CUNNINGHAM AA & HYATT AD Emerging Infectious Diseases of Wildlife Threats to Biodiversity and Human Health. Science, 2000, 287, 443449.
- FORMENTY P, BOESCH C, WYERS M, STEINER C, DONATI F et al. - Ebola Virus Outbreak among Wild Chimpanzees Living in a Rain Forest of Côte-d’Ivoire. J Infect Dis, 1999, 179, S 120-126.
- KILBOURN A, KARESH B & FROMENT JM Suivi de la santé animale et gestion des aires protégées. Canopée, 2002, 22, 1113.
- LEIRS H, MILLS JN, KREBS JW, CHILDS JE, AKAIBE D et al. - Search for the Ebola Virus Reservoir in Kikwit, Democratic Republic of the Congo: Reflections on a Vertebrate Collection. J Infect Dis, 1999, 179, S 155-163.
- LEROY EM, ROUQUET P, FORMENTY P, SOUQUIÈRE S, KILBOURNE A et al. Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife. Science, 2004, 303, 387390.
- LEROY EM, TELFER P, KUMULUNGUI B, YABA P, ROUQUET P, ROQUES P, GONZALEZ JP, KSIAZEK TG, ROLLIN PE, NERRIENET E A serological survey of Ebola virus infection in central African nonhuman primates. J Infect Dis, 2004, 190 (11), 1895-18999. Epub 2004 Nov 3.
- MONATH TP - Ecology of Marburg and Ebola Viruses: Speculations and Directions for Future Research. J Infect Dis, 1999, 179, S 127-138.
- MORVAN JM, NAKOUNE E, DEUBEL V & COLYN M Ecosystème forestier et virus Ebola. Bull Soc Pathol Exot, 2000, 93, 172-175.
[télécharger l'article / download article] (76 Ko)
- NAKOUNNE E, SELEKON B & MORVAN J Veille microbiologique : les fièvres hémorragiques virales en République centrafricaine; données sérologiques actualisées chez l’homme. Bull Soc Pathol Exot, 2000, 93, 343347.
[télécharger l'article / download article] (104 Ko)
- PETERSON AT, CARROLL DS, MILLS JN, JOHNSON KM. Potential mammalian filovirus reservoirs. Emerg Infect Dis, 2004, 10 (12), 2073-2081.
- PINZON JE, WILSON JM, TUCKER CJ, ARTHUR R, JAHRLING PB, FORMENTY P Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks. Am J Trop Med Hyg, 2004, 71 (5), 664-674.
- POURRUT X, KUMULUNGUI B, WITTMANN T, MOUSSAVOU G, DELICAT A, YABA P, NKOGHE D, GONZALEZ JP, LEROY EM The natural history of Ebola virus in Africa. Microbes Infect, 2005, 7 (7-8), 1005-1014.
- REITER P, TURELL M, COLEMAN R, MILLER B, MAUPIN G et al. - Field Investigations of an Outbreak of Ebola Hemorrhagic Fever, Kikwit, Democratic Republic of the Congo, 1995: Arthropod Studies. J Infect Dis, 1999, 179, S 148-154.
- ROUQUET P, FROMENT JM, BERMEJO M, YABA P, DELICAT A, ROLLIN PE, LEROY EM Wild animal mortality monitoring and human Ebola outbreaks, Gabon and Republic of Congo, 2001-2003. Emerg Infect Dis, 2005, 11 (2), 283-290.
- TOWNSEND PETERSON A, BAUER JT & MILLS JN Ecologic and Geographic Distribution of Filovirus Disease. Emerg Infect Dis, 2004, 10, 4047.
- WALSH PD, ABERNETHY KA, BERMEJO M, BEYERS R, DE WACHTER P et al. Catastrophic ape decline in western equatorial Africa. Nature (DOI:10.1038/nature01566, 2003, 6, 13).
- WOLFE ND, ESCALANTE AA, KARESH WB, KILBOURN A, SPIELMAN A & LAL AA Wild Primate Populations in Emerging Infectious Disease Research: The Missing Link? Emerging Infectious Diseases Perspectives, 1998, 4, 149158.
- WOLFE ND, SWITZER WM, CARR JK, BHULLAR VB, SHANMUGAM V et al. Naturally acquired simian retrovirus infections in central African hunters. The Lancet, 2004, 363, 932937.
[retour haut de page]
Revue critique des recommandations des quatre sessions et conclusion de la réunion
Critical review of the recommendations and conclusion of the workshop
REVIEW ARTICLES
- BLEASEDALE M - Ebola crisis. Nurs Times, 2001, 97, 14-15. No abstract available.
- CROWCROFT NS, MORGAN D& BROWN D Les fièvres hémorragiques virales en Europe. Un contrôle efficace exige une réponse coordonnée. Eurosurveillance, 2002, 7, 31-54.
- FELDMANN H, JONES S, KLENK HD, SCHNITTLER HJ Ebola virus: from discovery to vaccine. Nat Rev Immunol, 2003, 3 (8), 677-685. Review.
- MAHANTY S, BRAY M Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis, 2004, 4 (8), 487-498. Review.
- MURPHY FA & PETERS CJ Ebola Virus: Where Does It Come From And Where Is It Going? 2000.
- PETERS CJ Filoviridae Marburg and Ebola virus hemorrhagic fevers. In: Mandell, Bennett, and Douglas, 5th ed, 1999.
- PETERS CJ Marburg and Ebola: arming ourselves against the deadly filoviruses. N Engl J Med, 2005, 352 (25), 2571-2573.
- PETERS CJ & LEDUC JW - An Introduction to Ebola: The Virus and the Disease. J Infect Dis, 1999, 179, S IX-XVI.
- PETERS CJ, SANCHEZ A, ROLLIN PE, KSIAZEK TG & MURPHY FA Filoviridae: Marburg And Ebola Viruses. Virology, 1994.
- ROLLIN PE, KSIAZEK TG, SANCHEZ A & ZAKI SR - Ebola hemorrhagic fever: emerging or not ?
[retour haut de page]
Sélection de quelques articles se rapportant au virus MARBURG
- BAUSCH DG, BORCHERT M, GREIN T, ROTH C, SWANEPOEL R, LIBANDE ML, TALARMIN A, BERTHERAT E, MUYEMBE-TAMFUM JJ, TUGUME B, COLEBUNDERS R, KONDE KM, PIRAD P, OLINDA LL, RODIER GR, CAMPBELL P, TOMORI O, KSIAZEK TG & ROLLIN PE Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo. Emerg Infect Dis, 2003, 9 (12),1531-1537.
- BORCHERT M, MULANGU S, SWANEPOEL R, TSHOMBA A, AFOUNDE A, KULIDRI A, MUYEMBE-TAMFUM JJ & VAN DER STUYFT P Pygmy populations seronegative for Marburg virus. Emerg Infect Dis, 2005, 11 (1), 174-177.
- BORCHERT M, MUYEMBE-TAMFUM JJ, COLEBUNDERS R, LIBANDE M, SABUE M & VAN DER STUYFT P Short communication: a cluster of Marburg virus disease involving an infant. Trop Med Int Health, 2002, 7 (10), 902-906.
- COLEBUNDERS R, SLEURS H, PIRARD P, BORCHERT M, LIBANDE M, MUSTIN JP, TSHOMBA A, KINUANI L, OLINDA LA, TSHIOKO F & MUYEMBE-TAMFUM JJ Organisation of health care during an outbreak of Marburg haemorrhagic fever in the Democratic Republic of Congo, 1999. J Infect, 2004, 48 (4), 347-353.
- KOLESNIKOVA L, BAMBERG S, BERGHOFER B & BECKER S The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J Virol, 2004, 78 (5), 2382-293.
- HEVEY M, NEGLEY D & SCHMALJOHN A Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes. Virology, 2003, 314 (1), 350-357.
- MARTINI GA & SIEGERT R Marburg virus disease. Springer-Verlag, Berlin, Heidelberg, New York, 1971, 230 pages.
- NDAYIMIRIJE N & KINDHAUSER MK Marburg hemorrhagic fever in Angola: fighting fear and a lethal pathogen. N Engl J Med, 2005, 352 (21), 2155-2157.
- Organisation Mondiale de la Santé Fièvre hémorragique virale/Marburg, République démocratique du Congo. Relevé Epidémiologique Hebdomadaire, 1999, 74 (20), 157-164.
- SMITH CE, SIMPSON DI, BOWEN ET & ZLOTNIK I Fatal human disease from vervet monkeys. Lancet, 1967, 2 (7526) 1119-1121.
- SIMPSON DIH Viral haemorrhagic fevers of man. Bull World Health Organ, 1978, 56 (6), 819-832.
- SIMPSON DIH Marburg and Ebola virus infections : a guide for their diagnosis, management and control. WHO offset publication n°36. World Health Organization, Geneva, 1977.
- WARFIELD KL, SWENSON DL, NEGLEY DL, SCHMALJOHN AL, AMAN MJ, BAVARI S Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection. Vaccine, 2004, 22 (25-26), 3495-3502.
[retour haut de page]